# PowerAssert Radio-Frequency (RF) Guidewire Coronary In-Stent Chronic Total Occlusion (CTO)

> **NCT01131793** · PHASE2 · COMPLETED · sponsor: **Stereotaxis** · enrollment: 5 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** PowerAssert RF wire in crossing coronary in-stent chronic total occlusions

## Key facts

- **NCT ID:** NCT01131793
- **Lead sponsor:** Stereotaxis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2011-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01131793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01131793, "PowerAssert Radio-Frequency (RF) Guidewire Coronary In-Stent Chronic Total Occlusion (CTO)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01131793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*